Lu, Y., Chen, D., Liang, J., Gao, J., Luo, Z., Wang, R., . . . Huang, H. (2019). Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: A multicenter randomized controlled study. BMC.
Chicago Style (17th ed.) CitationLu, Ying, et al. Administration of Nimotuzumab Combined with Cisplatin Plus 5-fluorouracil as Induction Therapy Improves Treatment Response and Tolerance in Patients with Locally Advanced Nasopharyngeal Carcinoma Receiving Concurrent Radiochemotherapy: A Multicenter Randomized Controlled Study. BMC, 2019.
MLA (9th ed.) CitationLu, Ying, et al. Administration of Nimotuzumab Combined with Cisplatin Plus 5-fluorouracil as Induction Therapy Improves Treatment Response and Tolerance in Patients with Locally Advanced Nasopharyngeal Carcinoma Receiving Concurrent Radiochemotherapy: A Multicenter Randomized Controlled Study. BMC, 2019.